HDL Cholesterol Kits Market Size Opportunities,Share, Emergi...| MENAFN.COM

Tuesday, 27 September 2022 02:15 GMT

HDL Cholesterol Kits Market Size Opportunities,Share, Emerging Trends, Technological Innovation And Forecast 2022-2031


(MENAFN- Comserve)

Shibuya-ku, Tokyo, Japan, Japan, May 26, 2022, 03:41 /Comserve / -- HDL Cholesterol Kits Market With Top Countries Data, Industry Analysis , Size, Share, Revenue, Prominent Players, Developing Technologies, Tendencies and Forecast

The HDL Cholesterol Kits market studied was projected to grow with a CAGR of 6.2% over the forecast period. The major factor attributing to the growth of the market is the increase in the prevalence of obesity and hyperlipidemia. According to the World Health Organization, in 2018, 40 million children under the age of 5 years were overweight or obese. According to OECD, Obesity levels are expected to be particularly high in the United States, Mexico, and England, where 47%, 39% and 35% of the population respectively are projected to be obese in 2030. Furthermore, the growing importance of cholesterol screening diabetics patients and increasing awareness programs on high cholesterol is boosting the market growth. However, errors and inaccuracy in HDL Cholesterol testing kits constraints the market.

Get the inside scoop with Sample report- 

Key Market Trends

HDL and LDL/VLDL Assay Kit Segment is Dominating the HDL Cholesterol Kits Market.


HDL and LDL/VLDL Assay Kit is a quantitative colorimetric determination of HDL and LDL/VLDL cholesterol. Lipoproteins are strong predictors for coronary heart disease. Functional HDL offers protection by removing cholesterol from cells and atheroma. Higher concentrations of LDL and lower concentrations of functional HDL are strongly associated with cardiovascular disease due to a higher risk of atherosclerosis. The balances between high and low-density lipoproteins are solely genetically determined but can be changed by medications, food choices and other factors. The dominant share of the segment over the other is due to the varied range of function, by using these kits one can measure all the three type of lipoproteins, unlike the HDL cholesterol direct reagent kit. Furthermore, the increasing prevalence of obesity and hyperlipidemia is propelling the segment growth.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to the factors such as the presence of key players, high prevalence of obesity and hyperlipidemia in the region, established healthcare infrastructure are some of the key factors accountable for its large share in the market. In this region the United States has the maximum share due to supportive healthcare policies, a high number of patients, and a developed healthcare market. According to the CDC, the prevalence of obesity was 42.4% in 2017-2018. As per the statistics, the increasing patient pool and increasing disposable revenue in this country boost the market growth of the region.

Competitive Landscape

The HDL Cholesterol Kits market is moderately competitive and consists of several major players. The major players of HDL cholesterol kits are focusing on the expansion of their presence in key markets such as the Asia Pacific, the Middle East, and Europe through distribution agreements and the opening of new manufacturing facilities. Some of the companies which are currently dominating the market are Abbott, Randox Laboratories Ltd., Thermo Fisher Scientific, Abcam plc, Merck KGaA, PerkinElmer, Inc, Diazyme Laboratories, Inc, Cell Biolabs, Inc., Oscar Medicare Pvt. Ltd.

Download Sample PDF of this Report: - 

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of Obesity and Hyperlipidaemia
4.2.2 Growing Importance of Cholesterol Screening among Diabetic Patients
4.2.3 Growing Awareness Programs for Risk High Cholesterol
4.3 Market Restraints
4.3.1 Errors and Inaccuracy in HDL Cholesterol Testing Methods
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

Ask for it and browse full report- HDL Cholesterol Kits Market

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.


MENAFN26052022004694010674ID1104276320


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.